bf/NASDAQ:REGN_icon.jpeg

COM:REGENERON

Regeneron Pharmaceuticals, Inc.

  • Stock

USD

Last Close

744.50

22/11 21:00

Market Cap

116.07B

Beta: -

Volume Today

1.03M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
424.36M
-
348.07M
17.98%
636.06M
82.74%
895.52M
40.79%
1.20B
33.83%
2.44B
103.95%
2.12B
13.44%
3.51B
66.05%
8.08B
129.86%
4.34B
46.28%
3.95B
8.87%
depreciation and amortization
41.20M
-
52.69M
27.87%
74.91M
42.18%
104.75M
39.83%
145.47M
38.88%
148.20M
1.88%
210.30M
41.90%
235.90M
12.17%
286.20M
21.32%
341.40M
19.29%
421M
23.32%
deferred income tax
63.60M
-
-66.60M
204.72%
-121.62M
82.61%
-360.08M
196.06%
318.81M
188.54%
-140M
143.91%
-130.60M
6.71%
75.60M
157.89%
-147.10M
294.58%
-746.40M
407.41%
-837.80M
12.25%
stock based compensation
198.40M
-
307.24M
54.86%
459.05M
49.41%
559.88M
21.96%
507.28M
9.40%
427.40M
15.75%
464.30M
8.63%
432M
6.96%
601.70M
39.28%
725M
20.49%
885M
22.07%
change in working capital
-190.67M
-
20.24M
110.61%
229.83M
1,035.56%
228.19M
0.71%
-926.53M
506.04%
-697M
24.77%
-200.50M
71.23%
-1.50B
649.93%
-1.92B
27.46%
-243.30M
87.30%
-94.10M
61.32%
accounts receivables
-198.66M
-
-62.43M
68.57%
-491.42M
687.13%
-143.83M
70.73%
-362.72M
152.19%
-268.90M
25.87%
-473.10M
75.94%
-1.36B
186.64%
-1.93B
42.13%
707.80M
136.72%
-338.80M
147.87%
inventory
-47.96M
-
-60.90M
26.99%
-111.83M
83.62%
-149.78M
33.94%
-314.19M
109.78%
-387.90M
23.46%
-335.50M
13.51%
-529.40M
57.79%
-494.30M
6.63%
-696.50M
40.91%
-271.70M
60.99%
accounts payables
136.68M
-
162.24M
18.69%
303.66M
87.17%
253.98M
16.36%
-23.19M
109.13%
210M
1,005.64%
444.50M
111.67%
118.90M
73.25%
866.10M
628.43%
-138.40M
115.98%
598.60M
532.51%
other working capital
-80.74M
-
-18.66M
76.88%
529.42M
2,936.41%
267.81M
49.41%
-226.43M
184.55%
-250.20M
10.50%
163.60M
165.39%
263M
60.76%
-360.90M
237.22%
-116.20M
67.80%
-82.20M
29.26%
other non cash items
133.65M
-
361.62M
170.57%
619.82M
71.40%
485.70M
21.64%
-36.90M
107.60%
12.10M
132.79%
-29.30M
342.15%
-135M
360.75%
181.70M
234.59%
599.80M
230.10%
266.30M
55.60%
net cash provided by operating activities
588.60M
-
752.43M
27.84%
1.33B
76.86%
1.49B
11.66%
1.31B
12.03%
2.20B
67.94%
2.43B
10.70%
2.62B
7.74%
7.08B
170.47%
5.01B
29.18%
4.59B
8.39%
investments in property plant and equipment
-156.32M
-
-333.01M
113.02%
-677.93M
103.58%
-511.90M
24.49%
-272.60M
46.75%
-383.10M
40.54%
-429.60M
12.14%
-614.60M
43.06%
-551.90M
10.20%
-590.10M
6.92%
-926.40M
56.99%
acquisitions net
1.07B
-
429.60M
59.85%
614.60M
43.06%
551.90M
10.20%
-230.30M
141.73%
-54.90M
76.16%
purchases of investments
-577.28M
-
-564.19M
2.27%
-557.11M
1.26%
-809.42M
45.29%
-1.28B
57.78%
-1.85B
44.50%
-3.20B
73.52%
-3.24B
1.21%
-7.05B
117.47%
-7.49B
6.24%
-11.65B
55.53%
sales maturities of investments
378.15M
-
476.42M
25.99%
327.44M
31.27%
274.46M
16.18%
544.58M
98.42%
775.60M
42.42%
1.60B
106.83%
3.79B
135.94%
2.22B
41.47%
5.55B
150.55%
9.44B
70.11%
other investing activites
-199.13M
-
-87.77M
55.92%
-229.67M
161.67%
-534.90M
132.90%
-732.60M
36.96%
-1.08B
47.41%
-429.60M
60.22%
-614.60M
43.06%
-551.90M
10.20%
-1.03B
86.05%
net cash used for investing activites
-355.45M
-
-420.78M
18.38%
-907.60M
115.70%
-1.05B
15.35%
-1.01B
3.99%
-1.46B
45.55%
-2.03B
38.61%
-70.60M
96.52%
-5.38B
7,527.05%
-3.78B
29.72%
-3.19B
15.84%
debt repayment
-2.02M
-
-221.73M
10,855.24%
-166.47M
24.92%
-40.58M
75.62%
-19.93M
50.90%
-1.50B
-
common stock issued
57.39M
-
126.05M
119.62%
206.36M
63.72%
126.74M
38.58%
240.21M
89.53%
114.50M
52.33%
211.80M
84.98%
2.58B
1,115.86%
1.67B
35.06%
1.52B
9.14%
1.15B
24.61%
common stock repurchased
-195.09M
-
-267.58M
37.16%
-160.54M
40.01%
-143.18M
10.81%
-301.69M
110.70%
-191.60M
36.49%
-463.90M
142.12%
-6.53B
1,307.11%
-2.68B
58.97%
-2.53B
5.59%
-2.94B
16.10%
dividends paid
-294.55M
-
-547.47M
85.86%
-500.18M
8.64%
-358.69M
28.29%
other financing activites
216.86M
-
448.56M
106.84%
405.32M
9.64%
-143.18M
135.33%
415.69M
390.32%
-188M
-
3.48B
1,952.07%
net cash used provided by financing activities
77.14M
-
-209.27M
371.29%
-262.80M
25.58%
-700.39M
166.52%
-24.40M
96.52%
-77.10M
215.98%
-252.10M
226.98%
-1.97B
681.63%
-1.01B
48.96%
-1.01B
0.32%
-1.79B
77.41%
effect of forex changes on cash
-400K
-
net change in cash
305.33M
-
113.11M
62.95%
160.38M
41.79%
-273.90M
270.78%
277.53M
201.33%
655M
136.01%
150.10M
77.08%
577M
284.41%
690.80M
19.72%
221.30M
67.96%
-381.60M
272.44%
cash at beginning of period
230.28M
-
535.61M
132.59%
648.72M
21.12%
809.10M
24.72%
535.20M
33.85%
825.20M
54.18%
1.48B
79.37%
1.63B
10.14%
2.21B
35.39%
2.90B
31.30%
3.12B
7.64%
cash at end of period
535.61M
-
648.72M
21.12%
809.10M
24.72%
535.20M
33.85%
812.73M
51.86%
1.48B
82.13%
1.63B
10.14%
2.21B
35.39%
2.90B
31.30%
3.12B
7.64%
2.74B
12.23%
operating cash flow
588.60M
-
752.43M
27.84%
1.33B
76.86%
1.49B
11.66%
1.31B
12.03%
2.20B
67.94%
2.43B
10.70%
2.62B
7.74%
7.08B
170.47%
5.01B
29.18%
4.59B
8.39%
capital expenditure
-156.32M
-
-333.01M
113.02%
-677.93M
103.58%
-511.90M
24.49%
-272.60M
46.75%
-383.10M
40.54%
-429.60M
12.14%
-614.60M
43.06%
-551.90M
10.20%
-590.10M
6.92%
-926.40M
56.99%
free cash flow
432.27M
-
419.43M
2.97%
652.85M
55.65%
974M
49.19%
1.03B
6.21%
1.81B
75.16%
2.00B
10.40%
2.00B
0.15%
6.53B
225.90%
4.42B
32.23%
3.67B
17.11%

All numbers in USD (except ratios and percentages)